These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 9818664)

  • 1. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty.
    Buckley LM; Marquez M; Hudson JO; Downs RW; Vacek P; Small RE; Poses R
    J Rheumatol; 1998 Nov; 25(11):2195-202. PubMed ID: 9818664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of corticosteroid-induced osteoporosis: results of a patient survey.
    Buckley LM; Marquez M; Feezor R; Ruffin DM; Benson LL
    Arthritis Rheum; 1999 Aug; 42(8):1736-9. PubMed ID: 10446875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective.
    Resch H; Walliser J; Phillips S; Wehren LE; Sen SS
    Curr Med Res Opin; 2007 Jun; 23(6):1227-37. PubMed ID: 17559732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.
    Adachi JD; Bensen WG; Bianchi F; Cividino A; Pillersdorf S; Sebaldt RJ; Tugwell P; Gordon M; Steele M; Webber C; Goldsmith CH
    J Rheumatol; 1996 Jun; 23(6):995-1000. PubMed ID: 8782129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid-induced osteoporosis.
    Joseph JC
    Am J Hosp Pharm; 1994 Jan; 51(2):188-97; quiz 229-30. PubMed ID: 8160669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD; Cheah SP; Taylor K; Ahern MJ
    J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid osteoporosis: practical implications of recent trials.
    Sambrook PN
    J Bone Miner Res; 2000 Sep; 15(9):1645-9. PubMed ID: 10976984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
    Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
    Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.
    Amin S; LaValley MP; Simms RW; Felson DT
    Arthritis Rheum; 1999 Aug; 42(8):1740-51. PubMed ID: 10446876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis.
    Naunton M; Peterson GM; Jones G; Griffin GM; Bleasel MD
    J Rheumatol; 2004 Mar; 31(3):550-6. PubMed ID: 14994404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological prevention of osteoporosis in patients on corticosteroid medication].
    Lems WF; Jacobs JW; Netelenbos JC; Dijkmans BA; Bijlsma JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1904-8. PubMed ID: 9856175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid induced osteoporosis. Guidelines for treatment.
    Sambrook PN; Diamond T; Ferris L; Fiatarone-Singh M; Flicker L; MacLennan A; Nowson C; O'Neill S; Greville H; ;
    Aust Fam Physician; 2001 Aug; 30(8):793-6. PubMed ID: 11681155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Post-steroidal osteoporosis].
    Drozdzowska B; Pluskiewicz W
    Przegl Lek; 1999; 56(2):157-60. PubMed ID: 10375951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR; Shrader SP; Ragucci KR
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
    Buckley LM; Hillner BE
    J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose corticosteroid exposure and osteoporosis intervention in adults.
    Che M; Ettinger B; Nguyen MT; Pressman AR; Johnston J
    Ann Allergy Asthma Immunol; 2006 Oct; 97(4):497-501. PubMed ID: 17069105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doctors' beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention.
    Duyvendak M; Naunton M; van Roon EN; Brouwers JR
    J Clin Pharm Ther; 2011 Jun; 36(3):356-66. PubMed ID: 21545615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.